BridgeBio Pharma, Inc.

Historical 13F Holders

Symbol
BBIO
CUSIP
10806X102
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 99 42.8 M $1.48 B
2024 Q4 311 177 M $4.85 B
2024 Q3 288 173 M $4.40 B
2024 Q2 294 177 M $4.47 B
2024 Q1 291 176 M $5.56 B
2023 Q4 283 174 M $7.02 B
2023 Q3 256 162 M $4.26 B
2023 Q2 248 150 M $2.58 B
2023 Q1 255 153 M $2.53 B
2022 Q4 188 153 M $1.17 B
2022 Q3 196 145 M $1.44 B
2022 Q2 185 141 M $1.28 B
2022 Q1 200 143 M $1.46 B
2021 Q4 246 150 M $2.50 B
2021 Q3 229 140 M $6.56 B
2021 Q2 223 150 M $9.17 B
2021 Q1 224 149 M $9.17 B
2020 Q4 183 121 M $8.61 B
2020 Q3 140 118 M $4.39 B
2020 Q2 131 117 M $3.83 B
2020 Q1 106 113 M $3.28 B
2019 Q4 90 108 M $3.68 B
2019 Q3 78 103 M $2.22 B
2019 Q2 63 99.9 M $2.70 B